Victory Capital Management Inc. lifted its stake in Varex Imaging Co. (NASDAQ:VREX – Get Rating) by 69.1% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 52,278 shares of the company's stock after purchasing an additional 21,362 shares during the period. Victory Capital Management Inc. owned 0.13% of Varex Imaging worth $1,038,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Covestor Ltd bought a new position in shares of Varex Imaging in the 4th quarter worth $48,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Varex Imaging by 78.7% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,141 shares of the company's stock worth $194,000 after buying an additional 2,705 shares during the period. Teacher Retirement System of Texas acquired a new stake in Varex Imaging during the 4th quarter worth $242,000. Envestnet Asset Management Inc. acquired a new stake in Varex Imaging during the 4th quarter worth $251,000. Finally, GSA Capital Partners LLP acquired a new stake in Varex Imaging during the 4th quarter worth $270,000.
Get Varex Imaging alerts:Insider Buying and Selling at Varex Imaging
In other Varex Imaging news, Director Ruediger Naumann-Etienne sold 5,207 shares of Varex Imaging stock in a transaction dated Monday, June 6th. The stock was sold at an average price of $22.62, for a total value of $117,782.34. Following the sale, the director now owns 26,375 shares of the company's stock, valued at approximately $596,602.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 3.80% of the company's stock.
Varex Imaging Stock Performance
Shares of Varex Imaging stock opened at $22.31 on Tuesday. The company has a market capitalization of $887.94 million, a PE ratio of 36.57, a PEG ratio of 6.97 and a beta of 0.88. Varex Imaging Co. has a 12 month low of $18.90 and a 12 month high of $32.65. The company has a current ratio of 3.44, a quick ratio of 1.70 and a debt-to-equity ratio of 0.78. The stock's fifty day simple moving average is $21.54 and its 200 day simple moving average is $22.21.Varex Imaging (NASDAQ:VREX – Get Rating) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.21 by $0.16. Varex Imaging had a return on equity of 10.21% and a net margin of 3.03%. During the same quarter in the prior year, the firm posted $0.40 EPS. On average, research analysts predict that Varex Imaging Co. will post 0.64 EPS for the current year.
Varex Imaging Company Profile
(Get Rating)
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys.
Further Reading
- Get a free copy of the StockNews.com research report on Varex Imaging (VREX)
- 3 Blowout Earnings Reports That Could Mark Turning Points
- Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
- 3 Stocks Set to Lead the Nasdaq Bull Market
- Skyworks Solutions Is Worth A Look At These Prices
- MarketBeat Podcast: ESG – Profitably Invest Your Values
Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging Co. (NASDAQ:VREX – Get Rating).
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.